Publications by authors named "Michelle M Kouspou"

Article Synopsis
  • The Movember Global Action Plan 1 Unique tissue microarray (GAP1-UTMA) project aims to improve understanding of prostate cancer outcomes by creating annotated tissue microarrays from samples globally.
  • Three tissue microarrays were developed for distinct purposes: TMA1 focuses on high-risk localized prostate cancers, TMA2 investigates the effects of androgen deprivation therapy, and TMA3 analyzes molecular marker heterogeneity in metastatic prostate cancer.
  • The project provides a valuable resource for the prostate cancer research community to validate biomarkers and explore critical clinical questions related to disease progression and treatment responses.
View Article and Find Full Text PDF
Article Synopsis
  • - Prostate cancer varies greatly in its severity and treatment approaches, leading to a global need for improved screening and management practices.
  • - Movember conducted a landscape analysis with a diverse group of experts and patients to identify and prioritize the most pressing research needs in prostate cancer.
  • - The top three prioritized research needs are developing better diagnostic tests, improving risk stratification for active surveillance, and integrating companion diagnostics in clinical trials to enhance treatment predictions.
View Article and Find Full Text PDF

Heat shock protein 90 (HSP90) regulates multiple signalling pathways critical for tumour growth. As such, HSP90 inhibitors have been shown to act as effective anticancer agents in preclinical studies but, for a number of reasons, the same effect has not been observed in the clinical trials to date. One potential reason for this may be the presence of de novo or acquired resistance within the tumours.

View Article and Find Full Text PDF

Many anticancer therapeutic agents cause bone loss, which increases the risk of fractures that severely reduce quality of life. Thus, in drug development, it is critical to identify and understand such effects. Anticancer therapeutic and HSP90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) causes bone loss by increasing osteoclast formation, but the mechanism underlying this is not understood.

View Article and Find Full Text PDF

HSF1 (heat-shock factor 1) is the master regulator of the heat-shock response; however, it is also activated by cancer-associated stresses and supports cellular transformation and cancer progression. We examined the role of HSF1 in relation to cancer cell clonogenicity, an important attribute of cancer cells. Ectopic expression or HSF1 knockdown demonstrated that HSF1 positively regulated cancer cell clonogenic growth.

View Article and Find Full Text PDF

Directed cell migration is fundamental to both physiological and pathophysiological processes such as embryogenesis, wound healing, and cancer metastasis. A complex series of events are required for directional cell migration, which is initiated by a migration-promoting or chemotactic stimulus, resulting in cellular polarization and entry into a cyclical pattern of leading edge protrusion, adhesion, and retraction of the trailing edge allowing cell movement. Heat shock proteins such as Hsp27, Hsp90, alphaB-crystallin, as well as heat shock transcription factors, are important players in both physiological and pathophysiological cell migration.

View Article and Find Full Text PDF